Healthineers first quarter earnings lower on ramp-up costs

FRANKFURT (Reuters) - Siemens Healthineers' operating income slipped 11% in the first quarter of its fiscal year, despite higher revenues, as it sold less profitable imaging machines and incurred ramp-up costs for its new Atellica blood-testing machines. The German maker of diagnostic equipment said adjusted earnings before interest and tax declined to 484 million euros (£407.8 million) during the October-December period.That was below an average analyst estimate of 568 million euros,..